Covid-19 Impact on NK Cells Market, Global Research Reports 2020-2021
This report covers market size and forecasts of NK Cells, including the following market information:
Major competitors identified in this market include Chipscreen Biosciences (China), Affimed NV (Netherlands), Altor BioScience Corporation (USA), Innate Pharma SA (France), Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (USA), NantKwest Inc. (USA), Bristol-Myers Squibb (USA), NKT Therapeutics (USA), etc.
Based on the Region:
- Global NK Cells Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global NK Cells Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global NK Cells Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global NK Cells Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Major competitors identified in this market include Chipscreen Biosciences (China), Affimed NV (Netherlands), Altor BioScience Corporation (USA), Innate Pharma SA (France), Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (USA), NantKwest Inc. (USA), Bristol-Myers Squibb (USA), NKT Therapeutics (USA), etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
- Cancer
- Cardiovascular Diseases
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on NK Cells Industry
1.7 COVID-19 Impact: NK Cells Market Trends
2 GLOBAL NK CELLS QUARTERLY MARKET SIZE ANALYSIS
2.1 NK Cells Business Impact Assessment - COVID-19
2.1.1 Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global NK Cells Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global NK Cells Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global NK Cells Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global NK Cells Factory Price by Manufacturers
3.3 Location of Key Manufacturers NK Cells Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into NK Cells Market
3.5 Key Manufacturers NK Cells Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NK CELLS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mogamulizumab
1.4.2 Lorvotuzumab Mertansine
1.4.3 Others
4.2 By Type, Global NK Cells Market Size, 2019-2021
4.2.1 By Type, Global NK Cells Market Size by Type, 2020-2021
4.2.2 By Type, Global NK Cells Price, 2020-2021
5 IMPACT OF COVID-19 ON NK CELLS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Cancer
5.5.2 Cardiovascular Diseases
5.5.3 Others
5.2 By Application, Global NK Cells Market Size, 2019-2021
5.2.1 By Application, Global NK Cells Market Size by Application, 2019-2021
5.2.2 By Application, Global NK Cells Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Chipscreen Biosciences (China)
7.1.1 Chipscreen Biosciences (China) Business Overview
7.1.2 Chipscreen Biosciences (China) NK Cells Quarterly Production and Revenue, 2020
7.1.3 Chipscreen Biosciences (China) NK Cells Product Introduction
7.1.4 Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
7.2 Affimed NV (Netherlands)
7.2.1 Affimed NV (Netherlands) Business Overview
7.2.2 Affimed NV (Netherlands) NK Cells Quarterly Production and Revenue, 2020
7.2.3 Affimed NV (Netherlands) NK Cells Product Introduction
7.2.4 Affimed NV (Netherlands) Response to COVID-19 and Related Developments
7.3 Altor BioScience Corporation (USA)
7.3.1 Altor BioScience Corporation (USA) Business Overview
7.3.2 Altor BioScience Corporation (USA) NK Cells Quarterly Production and Revenue, 2020
7.3.3 Altor BioScience Corporation (USA) NK Cells Product Introduction
7.3.4 Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
7.4 Innate Pharma SA (France)
7.4.1 Innate Pharma SA (France) Business Overview
7.4.2 Innate Pharma SA (France) NK Cells Quarterly Production and Revenue, 2020
7.4.3 Innate Pharma SA (France) NK Cells Product Introduction
7.4.4 Innate Pharma SA (France) Response to COVID-19 and Related Developments
7.5 Takeda Pharmaceutical (Japan)
7.5.1 Takeda Pharmaceutical (Japan) Business Overview
7.5.2 Takeda Pharmaceutical (Japan) NK Cells Quarterly Production and Revenue, 2020
7.5.3 Takeda Pharmaceutical (Japan) NK Cells Product Introduction
7.5.4 Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
7.6 Sorrento Therapeutics Inc. (USA)
7.6.1 Sorrento Therapeutics Inc. (USA) Business Overview
7.6.2 Sorrento Therapeutics Inc. (USA) NK Cells Quarterly Production and Revenue, 2020
7.6.3 Sorrento Therapeutics Inc. (USA) NK Cells Product Introduction
7.6.4 Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
7.7 NantKwest Inc. (USA)
7.7.1 NantKwest Inc. (USA) Business Overview
7.7.2 NantKwest Inc. (USA) NK Cells Quarterly Production and Revenue, 2020
7.7.3 NantKwest Inc. (USA) NK Cells Product Introduction
7.7.4 NantKwest Inc. (USA) Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb (USA)
7.8.1 Bristol-Myers Squibb (USA) Business Overview
7.8.2 Bristol-Myers Squibb (USA) NK Cells Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb (USA) NK Cells Product Introduction
7.8.4 Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
7.9 NKT Therapeutics (USA)
7.9.1 NKT Therapeutics (USA) Business Overview
7.9.2 NKT Therapeutics (USA) NK Cells Quarterly Production and Revenue, 2020
7.9.3 NKT Therapeutics (USA) NK Cells Product Introduction
7.9.4 NKT Therapeutics (USA) Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 NK Cells Supply Chain Analysis
8.1.1 NK Cells Supply Chain Analysis
8.1.2 Covid-19 Impact on NK Cells Supply Chain
8.2 Distribution Channels Analysis
8.2.1 NK Cells Distribution Channels
8.2.2 Covid-19 Impact on NK Cells Distribution Channels
8.2.3 NK Cells Distributors
8.3 NK Cells Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on NK Cells Industry
1.7 COVID-19 Impact: NK Cells Market Trends
2 GLOBAL NK CELLS QUARTERLY MARKET SIZE ANALYSIS
2.1 NK Cells Business Impact Assessment - COVID-19
2.1.1 Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global NK Cells Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global NK Cells Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global NK Cells Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global NK Cells Factory Price by Manufacturers
3.3 Location of Key Manufacturers NK Cells Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into NK Cells Market
3.5 Key Manufacturers NK Cells Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NK CELLS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mogamulizumab
1.4.2 Lorvotuzumab Mertansine
1.4.3 Others
4.2 By Type, Global NK Cells Market Size, 2019-2021
4.2.1 By Type, Global NK Cells Market Size by Type, 2020-2021
4.2.2 By Type, Global NK Cells Price, 2020-2021
5 IMPACT OF COVID-19 ON NK CELLS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Cancer
5.5.2 Cardiovascular Diseases
5.5.3 Others
5.2 By Application, Global NK Cells Market Size, 2019-2021
5.2.1 By Application, Global NK Cells Market Size by Application, 2019-2021
5.2.2 By Application, Global NK Cells Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Chipscreen Biosciences (China)
7.1.1 Chipscreen Biosciences (China) Business Overview
7.1.2 Chipscreen Biosciences (China) NK Cells Quarterly Production and Revenue, 2020
7.1.3 Chipscreen Biosciences (China) NK Cells Product Introduction
7.1.4 Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
7.2 Affimed NV (Netherlands)
7.2.1 Affimed NV (Netherlands) Business Overview
7.2.2 Affimed NV (Netherlands) NK Cells Quarterly Production and Revenue, 2020
7.2.3 Affimed NV (Netherlands) NK Cells Product Introduction
7.2.4 Affimed NV (Netherlands) Response to COVID-19 and Related Developments
7.3 Altor BioScience Corporation (USA)
7.3.1 Altor BioScience Corporation (USA) Business Overview
7.3.2 Altor BioScience Corporation (USA) NK Cells Quarterly Production and Revenue, 2020
7.3.3 Altor BioScience Corporation (USA) NK Cells Product Introduction
7.3.4 Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
7.4 Innate Pharma SA (France)
7.4.1 Innate Pharma SA (France) Business Overview
7.4.2 Innate Pharma SA (France) NK Cells Quarterly Production and Revenue, 2020
7.4.3 Innate Pharma SA (France) NK Cells Product Introduction
7.4.4 Innate Pharma SA (France) Response to COVID-19 and Related Developments
7.5 Takeda Pharmaceutical (Japan)
7.5.1 Takeda Pharmaceutical (Japan) Business Overview
7.5.2 Takeda Pharmaceutical (Japan) NK Cells Quarterly Production and Revenue, 2020
7.5.3 Takeda Pharmaceutical (Japan) NK Cells Product Introduction
7.5.4 Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
7.6 Sorrento Therapeutics Inc. (USA)
7.6.1 Sorrento Therapeutics Inc. (USA) Business Overview
7.6.2 Sorrento Therapeutics Inc. (USA) NK Cells Quarterly Production and Revenue, 2020
7.6.3 Sorrento Therapeutics Inc. (USA) NK Cells Product Introduction
7.6.4 Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
7.7 NantKwest Inc. (USA)
7.7.1 NantKwest Inc. (USA) Business Overview
7.7.2 NantKwest Inc. (USA) NK Cells Quarterly Production and Revenue, 2020
7.7.3 NantKwest Inc. (USA) NK Cells Product Introduction
7.7.4 NantKwest Inc. (USA) Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb (USA)
7.8.1 Bristol-Myers Squibb (USA) Business Overview
7.8.2 Bristol-Myers Squibb (USA) NK Cells Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb (USA) NK Cells Product Introduction
7.8.4 Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
7.9 NKT Therapeutics (USA)
7.9.1 NKT Therapeutics (USA) Business Overview
7.9.2 NKT Therapeutics (USA) NK Cells Quarterly Production and Revenue, 2020
7.9.3 NKT Therapeutics (USA) NK Cells Product Introduction
7.9.4 NKT Therapeutics (USA) Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 NK Cells Supply Chain Analysis
8.1.1 NK Cells Supply Chain Analysis
8.1.2 Covid-19 Impact on NK Cells Supply Chain
8.2 Distribution Channels Analysis
8.2.1 NK Cells Distribution Channels
8.2.2 Covid-19 Impact on NK Cells Distribution Channels
8.2.3 NK Cells Distributors
8.3 NK Cells Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on NK Cells Assessment
Table 9. COVID-19 Impact: NK Cells Market Trends
Table 10. COVID-19 Impact Global NK Cells Market Size
Table 11. Global NK Cells Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global NK Cells Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)
Table 13. Global NK Cells Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global NK Cells Market Growth Drivers
Table 17. Global NK Cells Market Restraints
Table 18. Global NK Cells Market Opportunities
Table 19. Global NK Cells Market Challenges
Table 20. Key Manufacturers NK Cells Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, NK Cells Market Size, 2019 (MT) & (US$ Million)
Table 22. NK Cells Factory Price by Manufacturers 2020 (USD/Kg)
Table 23. Location of Key Manufacturers NK Cells Manufacturing Plants
Table 24. Key Manufacturers NK Cells Market Served
Table 25. Date of Key Manufacturers Enter into NK Cells Market
Table 26. Key Manufacturers NK Cells Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global NK Cells Market Size by Type, 2020, (US$ Million)
Table 29. Global NK Cells Market Size by Type, 2020 (MT)
Table 30. Global NK Cells Price: by Type, 2020-2021 (USD/Kg)
Table 31. Global NK Cells Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global NK Cells Market Size by Application, 2020-2021 (MT)
Table 33. Global NK Cells Price: by Application, 2020-2021 (USD/Kg)
Table 34. Global NK Cells Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global NK Cells Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America NK Cells Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America NK Cells Market Size, 2019-2021 (MT)
Table 38. US NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe NK Cells Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe NK Cells Market Size, 2019-2021 (MT)
Table 43. Germany NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific NK Cells Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific NK Cells Market Size, 2019-2021 (MT)
Table 50. China NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. Chipscreen Biosciences (China) Business Overview
Table 58. Chipscreen Biosciences (China) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Chipscreen Biosciences (China) NK Cells Product
Table 60. Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
Table 61. Affimed NV (Netherlands) Business Overview
Table 62. Affimed NV (Netherlands) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Affimed NV (Netherlands) NK Cells Product
Table 64. Affimed NV (Netherlands) Response to COVID-19 and Related Developments
Table 65. Altor BioScience Corporation (USA) Business Overview
Table 66. Altor BioScience Corporation (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Altor BioScience Corporation (USA) NK Cells Product
Table 68. Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
Table 69. Innate Pharma SA (France) Business Overview
Table 70. Innate Pharma SA (France) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Innate Pharma SA (France) NK Cells Product
Table 72. Innate Pharma SA (France) Response to COVID-19 and Related Developments
Table 73. Takeda Pharmaceutical (Japan) Business Overview
Table 74. Takeda Pharmaceutical (Japan) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Takeda Pharmaceutical (Japan) NK Cells Product
Table 76. Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
Table 77. Sorrento Therapeutics Inc. (USA) Business Overview
Table 78. Sorrento Therapeutics Inc. (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Sorrento Therapeutics Inc. (USA) NK Cells Product
Table 80. Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
Table 81. NantKwest Inc. (USA) Business Overview
Table 82. NantKwest Inc. (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. NantKwest Inc. (USA) NK Cells Product
Table 84. NantKwest Inc. (USA) Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb (USA) Business Overview
Table 86. Bristol-Myers Squibb (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb (USA) NK Cells Product
Table 88. Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
Table 89. NKT Therapeutics (USA) Business Overview
Table 90. NKT Therapeutics (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. NKT Therapeutics (USA) NK Cells Product
Table 92. NKT Therapeutics (USA) Response to COVID-19 and Related Developments
Table 93. NK Cells Distributors List
Table 94. NK Cells Customers List
Table 95. Covid-19 Impact on NK Cells Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on NK Cells Assessment
Table 9. COVID-19 Impact: NK Cells Market Trends
Table 10. COVID-19 Impact Global NK Cells Market Size
Table 11. Global NK Cells Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global NK Cells Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)
Table 13. Global NK Cells Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global NK Cells Market Growth Drivers
Table 17. Global NK Cells Market Restraints
Table 18. Global NK Cells Market Opportunities
Table 19. Global NK Cells Market Challenges
Table 20. Key Manufacturers NK Cells Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, NK Cells Market Size, 2019 (MT) & (US$ Million)
Table 22. NK Cells Factory Price by Manufacturers 2020 (USD/Kg)
Table 23. Location of Key Manufacturers NK Cells Manufacturing Plants
Table 24. Key Manufacturers NK Cells Market Served
Table 25. Date of Key Manufacturers Enter into NK Cells Market
Table 26. Key Manufacturers NK Cells Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global NK Cells Market Size by Type, 2020, (US$ Million)
Table 29. Global NK Cells Market Size by Type, 2020 (MT)
Table 30. Global NK Cells Price: by Type, 2020-2021 (USD/Kg)
Table 31. Global NK Cells Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global NK Cells Market Size by Application, 2020-2021 (MT)
Table 33. Global NK Cells Price: by Application, 2020-2021 (USD/Kg)
Table 34. Global NK Cells Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global NK Cells Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America NK Cells Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America NK Cells Market Size, 2019-2021 (MT)
Table 38. US NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe NK Cells Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe NK Cells Market Size, 2019-2021 (MT)
Table 43. Germany NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific NK Cells Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific NK Cells Market Size, 2019-2021 (MT)
Table 50. China NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa NK Cells Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. Chipscreen Biosciences (China) Business Overview
Table 58. Chipscreen Biosciences (China) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Chipscreen Biosciences (China) NK Cells Product
Table 60. Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
Table 61. Affimed NV (Netherlands) Business Overview
Table 62. Affimed NV (Netherlands) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Affimed NV (Netherlands) NK Cells Product
Table 64. Affimed NV (Netherlands) Response to COVID-19 and Related Developments
Table 65. Altor BioScience Corporation (USA) Business Overview
Table 66. Altor BioScience Corporation (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Altor BioScience Corporation (USA) NK Cells Product
Table 68. Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
Table 69. Innate Pharma SA (France) Business Overview
Table 70. Innate Pharma SA (France) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Innate Pharma SA (France) NK Cells Product
Table 72. Innate Pharma SA (France) Response to COVID-19 and Related Developments
Table 73. Takeda Pharmaceutical (Japan) Business Overview
Table 74. Takeda Pharmaceutical (Japan) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Takeda Pharmaceutical (Japan) NK Cells Product
Table 76. Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
Table 77. Sorrento Therapeutics Inc. (USA) Business Overview
Table 78. Sorrento Therapeutics Inc. (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Sorrento Therapeutics Inc. (USA) NK Cells Product
Table 80. Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
Table 81. NantKwest Inc. (USA) Business Overview
Table 82. NantKwest Inc. (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. NantKwest Inc. (USA) NK Cells Product
Table 84. NantKwest Inc. (USA) Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb (USA) Business Overview
Table 86. Bristol-Myers Squibb (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb (USA) NK Cells Product
Table 88. Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
Table 89. NKT Therapeutics (USA) Business Overview
Table 90. NKT Therapeutics (USA) NK Cells Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. NKT Therapeutics (USA) NK Cells Product
Table 92. NKT Therapeutics (USA) Response to COVID-19 and Related Developments
Table 93. NK Cells Distributors List
Table 94. NK Cells Customers List
Table 95. Covid-19 Impact on NK Cells Customers
LIST OF FIGURES
Figure 1. NK Cells Product Picture
Figure 2. NK Cells Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global NK Cells Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global NK Cells Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global NK Cells Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global NK Cells Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific NK Cells Market Size Market Share, 2019-2021
Figure 1. NK Cells Product Picture
Figure 2. NK Cells Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global NK Cells Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global NK Cells Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global NK Cells Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global NK Cells Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global NK Cells Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific NK Cells Market Size Market Share, 2019-2021
